Fox Run Management, L.L.C. Agenus Inc Transaction History

Fox Run Management, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$2.92 - $5.74 $39,951 - $78,534	-13,682 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.98 - $6.63 $68,136 - $90,711	13,682 New	13,682 $72,000
Q2 2018 Jul 17, 2018	SELL	$2.26 - $4.65 $97,559 - $200,731	-43,168 Closed	0 $0
Q1 2018 Apr 17, 2018	BUY	$3.51 - $6.04 $151,519 - $260,734	43,168 New	43,168 $203,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.